262 related articles for article (PubMed ID: 34362712)
1. COVID-19 vaccine perceptions in New York State's intellectual and developmental disabilities community.
Iadarola S; Siegel JF; Gao Q; McGrath K; Bonuck KA
Disabil Health J; 2022 Jan; 15(1):101178. PubMed ID: 34362712
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 outcomes among people with intellectual and developmental disability living in residential group homes in New York State.
Landes SD; Turk MA; Formica MK; McDonald KE; Stevens JD
Disabil Health J; 2020 Oct; 13(4):100969. PubMed ID: 32600948
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 case-fatality disparities among people with intellectual and developmental disabilities: Evidence from 12 US jurisdictions.
Landes SD; Turk MA; Ervin DA
Disabil Health J; 2021 Oct; 14(4):101116. PubMed ID: 34039516
[TBL] [Abstract][Full Text] [Related]
4. Covid-19 patterns among adults with intellectual and developmental disability and the general population in New York state during the first year of the pandemic.
Formica MK; Cox R; Christiana J; Turk MA; Landes SD
Disabil Health J; 2024 Jul; 17(3):101623. PubMed ID: 38631971
[TBL] [Abstract][Full Text] [Related]
5. The Role of Information and Knowledge in COVID-19 Vaccination Among People With Intellectual and Developmental Disabilities and Their Families.
Lineberry S; Bogenschutz M; Dinora P; Ayers K
Intellect Dev Disabil; 2023 Feb; 61(1):16-30. PubMed ID: 36706004
[TBL] [Abstract][Full Text] [Related]
6. The COVID-19 vaccine intentions of Australian disability support workers.
Kavanagh A; Dickinson H; Dimov S; Shields M; McAllister A
Aust N Z J Public Health; 2022 Jun; 46(3):314-321. PubMed ID: 35298057
[TBL] [Abstract][Full Text] [Related]
7. Vaccine hesitancy among working-age adults with/without disability in the UK.
Emerson E; Totsika V; Aitken Z; King T; Hastings RP; Hatton C; Stancliffe RJ; Llewellyn G; Kavanagh A
Public Health; 2021 Nov; 200():106-108. PubMed ID: 34715531
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccination hesitancy among Americans with disabilities aged 18-65: An exploratory analysis.
Myers A; Ipsen C; Lissau A
Disabil Health J; 2022 Jan; 15(1):101223. PubMed ID: 34663563
[TBL] [Abstract][Full Text] [Related]
9. Quality of life, satisfaction with care, and the experiences of adults with intellectual and developmental disabilities before and during COVID-19.
Hickey EJ; Caudill A; Laufenberg H; Hrabik L; DaWalt L; Ausderau KK
Disabil Health J; 2024 Apr; 17(2):101545. PubMed ID: 37980230
[TBL] [Abstract][Full Text] [Related]
10. Telehealth information and communication technology access for family caregivers of people with intellectual and developmental disabilities and mental health needs.
Kramer JM; Guerrero F; Caoili A; Beasley JB; Kalb L; Klein A; Goode TD
Disabil Health J; 2023 Jul; 16(3):101463. PubMed ID: 37024396
[TBL] [Abstract][Full Text] [Related]
11. Examining drivers of coronavirus disease 2019 (COVID-19) vaccine hesitancy among healthcare workers.
Swann MC; Bendetson J; Johnson A; Jatta M; Schleupner CJ; Baffoe-Bonnie A
Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1813-1821. PubMed ID: 35156600
[TBL] [Abstract][Full Text] [Related]
12. The COVID-19 pandemic and quality of life outcomes of people with intellectual and developmental disabilities.
Friedman C
Disabil Health J; 2021 Oct; 14(4):101117. PubMed ID: 34144897
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 outcomes among people with intellectual and developmental disability in California: The importance of type of residence and skilled nursing care needs.
Landes SD; Turk MA; Wong AWWA
Disabil Health J; 2021 Apr; 14(2):101051. PubMed ID: 33309535
[TBL] [Abstract][Full Text] [Related]
14. Predictors of COVID-19 Vaccine Uptake and Reasons for Vaccine Hesitancy Among New York State Refugees.
Disney L; Ahmed R; Moon Y; Carnes S
J Evid Based Soc Work (2019); 2023 Sep; 20(5):653-667. PubMed ID: 37461308
[TBL] [Abstract][Full Text] [Related]
15. Short Report: The influence of congregate setting on positive COVID-19 tests among a high-risk sample of adults with intellectual and developmental disability in Ontario.
Hansford R; Ouellette-Kuntz H; Martin L
Res Dev Disabil; 2022 Mar; 122():104178. PubMed ID: 35063714
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors Associated With COVID-19 Outcomes Among People With Intellectual and Developmental Disabilities Receiving Residential Services.
Landes SD; Turk MA; Damiani MR; Proctor P; Baier S
JAMA Netw Open; 2021 Jun; 4(6):e2112862. PubMed ID: 34100935
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
[TBL] [Abstract][Full Text] [Related]
18. Facilitators of COVID-19 vaccine acceptance among Black and Hispanic individuals in New York: A qualitative study.
Osakwe ZT; Osborne JC; Osakwe N; Stefancic A
Am J Infect Control; 2022 Mar; 50(3):268-272. PubMed ID: 34793893
[TBL] [Abstract][Full Text] [Related]
19. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
20. Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis.
Turk MA; Landes SD; Formica MK; Goss KD
Disabil Health J; 2020 Jul; 13(3):100942. PubMed ID: 32473875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
